200 related articles for article (PubMed ID: 9884539)
21. [Transfusion of blood and products derived from blood].
Wautier JL
Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
[No Abstract] [Full Text] [Related]
22. Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application.
Corash L
Transfus Apher Sci; 2001 Dec; 25(3):179-81. PubMed ID: 11846134
[No Abstract] [Full Text] [Related]
23. [The problems of modern transfusion science].
Vorob'ev AI; Dabberkha NM
Ter Arkh; 1991; 63(7):4-9. PubMed ID: 1788805
[No Abstract] [Full Text] [Related]
24. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.
O'Mahony B; Turner A
Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632
[No Abstract] [Full Text] [Related]
25. In search of safer blood.
Cowley G; Springen K; Hager M
Newsweek; 1992 Aug; 120(6):44-5. PubMed ID: 10120443
[No Abstract] [Full Text] [Related]
26. When, why and how to order blood?
Steenssens L
Acta Anaesthesiol Belg; 2003; 54(4):313-4. PubMed ID: 14719351
[No Abstract] [Full Text] [Related]
27. Decreasing the risk of allogenic blood in the 21st century.
Popovsky MA; O'Neill EM; Cannon M
Med Health R I; 1998 Dec; 81(12):392-5. PubMed ID: 9884538
[No Abstract] [Full Text] [Related]
28. [Towards bacterial detection in labile blood products].
Morel P
Transfus Clin Biol; 2005 Jun; 12(2):215-20. PubMed ID: 15894499
[TBL] [Abstract][Full Text] [Related]
29. [Virus safety of labile plasma products from the German viewpoint].
Stephan W
Beitr Infusionsther; 1989; 24():40-5. PubMed ID: 2481547
[TBL] [Abstract][Full Text] [Related]
30. [Hematology and the transfusion service. A collection of guidelines, methodologic instructions, technical standards, methodologic lists and research methods].
Dobrý E; Kvasnicka J
Zdrav Aktual; 1987; 211():1-310. PubMed ID: 3270290
[No Abstract] [Full Text] [Related]
31. Properties of pathogen-inactivated plasma components.
Prowse C
Transfus Med Rev; 2009 Apr; 23(2):124-33. PubMed ID: 19304113
[TBL] [Abstract][Full Text] [Related]
32. [Bacterial detection leading to pathogen inactivation].
Morel P; Deschaseaux M; Naegelen C; Bardiaux L; des Floris MF; Pouthier F
Transfus Clin Biol; 2005 Jun; 12(2):142-9. PubMed ID: 15894506
[TBL] [Abstract][Full Text] [Related]
33. The use of blood products in shock.
Nacht A
Crit Care Clin; 1992 Apr; 8(2):255-91. PubMed ID: 1568140
[TBL] [Abstract][Full Text] [Related]
34. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy.
Hellstern P; Haubelt H
Thromb Res; 2002 Oct; 107 Suppl 1():S3-8. PubMed ID: 12379286
[TBL] [Abstract][Full Text] [Related]
35. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):584. PubMed ID: 23529604
[No Abstract] [Full Text] [Related]
36. [Experience with the regionalization of transfusion advice].
Courbil R; Fabrigli P; Benamara H; Chavarin P; Bregeon M; Ruyer-Dumontier P; Goure D; Paulin P; Froget A; Taibi K; Rigal E; Garraud O
Transfus Clin Biol; 2009 Mar; 16(1):4-11. PubMed ID: 19324582
[TBL] [Abstract][Full Text] [Related]
37. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment. Explanation to comment].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):585-9. PubMed ID: 23529605
[No Abstract] [Full Text] [Related]
38. [Problems of the control of the quality of blood components].
Galkin VV; Golubeva VL; Ataullakhanov FI; Kazanets EG; Pushkar' LN
Gematol Transfuziol; 1991 Jan; 36(1):37-40. PubMed ID: 2065948
[No Abstract] [Full Text] [Related]
39. Bacterial contamination of blood components.
García-Erce JA; Solano VM; Seoane A; Giralt M
Vox Sang; 2000; 79(4):249-50. PubMed ID: 11155082
[No Abstract] [Full Text] [Related]
40. General overview of blood products in vitro quality: Processing and storage lesions.
Abonnenc M; Tissot JD; Prudent M
Transfus Clin Biol; 2018 Nov; 25(4):269-275. PubMed ID: 30241785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
